Page 25 - Confidence Interval News Today

1. In this randomized controlled trial, compared to heart transplantation from a brain death donor, recipients of hearts from donors following circulatory death had similar six-month survival. 2. There were no significant differences in the number of serious adverse events 30 days post-operatively between standard-care and post-circulatory death transplantation. Evidence Rating Level: 1 (Excellent) Study

1. In this randomized controlled trial, craniotomy and decompressive craniectomy resulted in similar disability and quality-of-life outcomes for patients following traumatic acute subdural hematoma. 2. Additional surgery was performed more frequently after craniotomy, but craniectomy was associated with more wound complications. Evidence Rating Level: 1 (Excellent) Study Rundown: Post-traumatic subdural hematoma is associated with high

Data from SURMOUNT-2 presented at ADA 2023 build on results from the SURMOUNT-1 trial, with results detailing the weight loss achieved with tirzepatide in people with type 2 diabetes and overweight or obesity.

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2023--

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2023--

1. In this randomized controlled trial, the treatment of gestational diabetes before 20 weeks' gestation was associated with a lower risk of adverse neonatal outcomes compared to no treatment. 2. There was no significant difference between treatment and no treatment with respect to maternal hypertension or neonatal lean body mass. Evidence Rating Level: 1 (Excellent)

1. Among patients with severe community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU), hydrocortisone reduced the risk of death compared to placebo. 2. The frequency of adverse events was similar between the hydrocortisone and placebo groups. Evidence Rating Level: 1 (Excellent) Study Rundown: CAP is a prevalent lower respiratory infection affecting millions of

/PRNewswire/ -- On May 17th, the 12-month results of the DRAGONFLY-DMR pivotal trial were presented at EuroPCR 2023. This trial was led by Professor Jianan...

Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description We begin this episode by discussing our article of the week comes from the New

1. In this retrospective study of Medicare claims data from 2016 to 2019, receipt of opioid use disorder (OUD) medications (buprenorphine and naloxone) was lower among Black and Hispanic patients than White patients after OUD-related adverse events. 2. Analysis of available methadone receipt data from 2020 to 2021 showed that Black patients received either buprenorphine